Complex interaction of Hb Hekinan [alpha27(B8) Glu-Asp] and Hb E [beta26(B8) Glu-Lys] with a deletional alpha-thalassemia 1 in a Thai family. 2003

Supan Fucharoen, and Yossombat Changtrakun, and Thawalwong Ratanasiri, and Goonnapa Fucharoen, and Kanokwan Sanchaisuriya
Department of Clinical Chemistry, Faculty of Associated Medical Sciences, Khon Kaen University, Khon Kaen, Thailand. supan@mail.kku.ac.th

Hemoglobin (Hb) Hekinan (alpha27; Glu-Asp) is a rare alpha-chain variant found mainly in Japanese and Chinese whereas Hb E (beta26; Glu-Lys) is common among Southeast Asians. We report a hitherto undescribed condition in which these two variants co-segregate. The proband was a 25-yr-old Thai woman who was encountered with the presence of mild hypochromic microcytosis with Hb 8.2 g/dL, hematocrit (Hct) 26.0%, Mean Corpuscular Value (MCV) 68.6 fL, Mean Corpuscular Hemoglobin (MCH) 21.6 pg and Mean Corpuscular Hemoglobin Concentration (MCHC) 31.5 g/dL. Although Hb electrophoresis at alkaline pH did not show any abnormal band except Hb E in addition to Hb A, high performance liquid chromatography analysis revealed abnormal peaks at the Hb A and Hb E positions. DNA analysis of the proband revealed a GAG-GAT mutation at codon 27 of the minor alpha1-globin gene for Hb Hekinan in trans to the South-east Asian (SEA) deletional alpha-thalassemia 1 determinant and a GAG-AAG mutation at codon 26 of the beta-globin gene for Hb E. She was therefore a triple heterozygote for these three anomalies. Family study identified that her mother was a double heterozygote for Hb Hekinan and Hb E without alpha-thalassemia whereas her father was a classical Hb H disease patient. The genotype-phenotype relationship observed in this Thai family with complex hemoglobinopathies is presented and a simple DNA assay based on the polymerase chain reaction methodology for rapid diagnosis of Hb Hekinan is described.

UI MeSH Term Description Entries
D008297 Male Males
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D012150 Polymorphism, Restriction Fragment Length Variation occurring within a species in the presence or length of DNA fragment generated by a specific endonuclease at a specific site in the genome. Such variations are generated by mutations that create or abolish recognition sites for these enzymes or change the length of the fragment. RFLP,Restriction Fragment Length Polymorphism,RFLPs,Restriction Fragment Length Polymorphisms
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D004252 DNA Mutational Analysis Biochemical identification of mutational changes in a nucleotide sequence. Mutational Analysis, DNA,Analysis, DNA Mutational,Analyses, DNA Mutational,DNA Mutational Analyses,Mutational Analyses, DNA
D005260 Female Females
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006446 Hemoglobin E An abnormal hemoglobin that results from the substitution of lysine for glutamic acid at position 26 of the beta chain. It is most frequently observed in southeast Asian populations.
D006447 Hemoglobin H An abnormal hemoglobin composed of four beta chains. It is caused by the reduced synthesis of the alpha chain. This abnormality results in ALPHA-THALASSEMIA.
D006455 Hemoglobins, Abnormal Hemoglobins characterized by structural alterations within the molecule. The alteration can be either absence, addition or substitution of one or more amino acids in the globin part of the molecule at selected positions in the polypeptide chains. Abnormal Hemoglobins

Related Publications

Supan Fucharoen, and Yossombat Changtrakun, and Thawalwong Ratanasiri, and Goonnapa Fucharoen, and Kanokwan Sanchaisuriya
January 2005, Hemoglobin,
Supan Fucharoen, and Yossombat Changtrakun, and Thawalwong Ratanasiri, and Goonnapa Fucharoen, and Kanokwan Sanchaisuriya
January 2009, Hemoglobin,
Supan Fucharoen, and Yossombat Changtrakun, and Thawalwong Ratanasiri, and Goonnapa Fucharoen, and Kanokwan Sanchaisuriya
May 2004, Hemoglobin,
Supan Fucharoen, and Yossombat Changtrakun, and Thawalwong Ratanasiri, and Goonnapa Fucharoen, and Kanokwan Sanchaisuriya
October 2004, Clinical and laboratory haematology,
Supan Fucharoen, and Yossombat Changtrakun, and Thawalwong Ratanasiri, and Goonnapa Fucharoen, and Kanokwan Sanchaisuriya
May 2002, Hemoglobin,
Supan Fucharoen, and Yossombat Changtrakun, and Thawalwong Ratanasiri, and Goonnapa Fucharoen, and Kanokwan Sanchaisuriya
January 1992, Hemoglobin,
Supan Fucharoen, and Yossombat Changtrakun, and Thawalwong Ratanasiri, and Goonnapa Fucharoen, and Kanokwan Sanchaisuriya
July 2011, European journal of haematology,
Supan Fucharoen, and Yossombat Changtrakun, and Thawalwong Ratanasiri, and Goonnapa Fucharoen, and Kanokwan Sanchaisuriya
January 1991, Hemoglobin,
Supan Fucharoen, and Yossombat Changtrakun, and Thawalwong Ratanasiri, and Goonnapa Fucharoen, and Kanokwan Sanchaisuriya
January 1988, Hemoglobin,
Supan Fucharoen, and Yossombat Changtrakun, and Thawalwong Ratanasiri, and Goonnapa Fucharoen, and Kanokwan Sanchaisuriya
January 1991, Hemoglobin,
Copied contents to your clipboard!